Biopharmaceuticals

Investment demand: High value-added industries that are able to fully rely on the advantages of Qinzhou Port's coastal location, and comply with the current market demand.

Relying on the advantageous coastal resources of Qinzhou, China-Malaysia Investment Holding Group focuses on the biotechnology production of biopharmaceuticals, health products, and genetic engineering drugs using marine flora and fauna as extraction materials. With the professional advantages of Shenzhen Bay Laboratory in the field of biopharmaceutical research and development, the group has promoted the commercialization of scientific and technological achievements, accelerated the development of industrial clusters, and established an internationally competitive and regionally driven international biopharmaceutical port.